Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06190717 · ClinicalTrials.gov registry record · NA
Maturation of Arteriovenous Fistula With Automated Sonography Assessments Trial
A NA study of Diabetes and End Stage Renal Disease, sponsored by Sonavex.
- Recruiting
- Registry status
- NA
- Development phase
- 304
- Enrollment target
- 20
- Study locations
NCT06190717 is a NA study of Diabetes and End Stage Renal Disease that is actively recruiting participants, run by Sonavex. The registered enrollment target is 304 participants, below the 3,027-participant average among 338 other Diabetes trials with a reported enrollment target (90% lower). The trial reports 20 study locations across 14 states.
The verdict
NCT06190717, a NA study of Diabetes and End Stage Renal Disease, is actively recruiting participants, sponsored by Sonavex.
- RECRUITING
- Registry status
- NA
- Development phase
- 304 participants
- Enrollment target
- 20
- Study locations
Study Summary
This is a prospective, multi-center, two-arm, randomized trial to quantify the performance of the EchoMark®/EchoSure® System for AVF diagnostic ultrasound when used under a protocol of biweekly use for assessing fistula maturation and reducing time to Clinical Maturation.
Conditions Studied
Interventions
- DEVICE EchoMark/EchoSure
- PROCEDURE Standard of Care
Study Locations (20)
Arizona
- Southwest Kidney Institute - Phoenix
- AKDHC Medical Research Services - Phoenix
- AKDHC Center Tucson - Tucson
South Carolina
- Prisma Health - Greenville
- Medical University of South Carolina Health Orangeburg - Orangeburg
Tennessee
- Galen Medical Group - Chattanooga
- Fresenius Vascular Care Memphis MSO - Memphis
Texas
- Baylor Scott & White Heart and Vascular Hospital - Dallas
- Aqua Research Institute Llc - Houston
Virginia
- Physicians Care of Virginia - Roanoke
- Sentara Health - Virginia Beach
Alabama
- Trinity Research Group - Dothan
Florida
- Orlando Health Heart and Vascular Institute - Orlando
Illinois
- Northwestern University - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 304 participants |
| Start Date | 2024-02-21 |
| Est. Completion | 2026-02-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06190717
The ClinicalTrials.gov registry entry for NCT06190717 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 304 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,027-participant average among 338 other Diabetes trials with a reported enrollment target (90% lower). The listed sponsor is Sonavex, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Diabetes appearing as the primary indexed condition, and to 2 interventions - of which EchoMark/EchoSure is the first listed.
NCT06190717 reports 20 study locations spanning 14 distinct geographic areas - top geographies include Arizona, South Carolina, Tennessee.
Frequently Asked Questions
What is clinical trial NCT06190717 about?
NCT06190717 is a clinical study titled "Maturation of Arteriovenous Fistula With Automated Sonography Assessments Trial". This is a prospective, multi-center, two-arm, randomized trial to quantify the performance of the EchoMark®/EchoSure® System for AVF diagnostic ultrasound when used under a protocol of biweekly use for assessing fistula maturation and reducing time to Clinical Maturation.
What is the current status of trial NCT06190717?
This trial is currently recruiting. It is a NA study. The enrollment target is 304 participants. The study started on 2024-02-21. Estimated completion is 2026-02-01.
What conditions does trial NCT06190717 study?
This clinical trial studies the following conditions: Diabetes, End Stage Renal Disease.
What interventions are being tested in trial NCT06190717?
The interventions under investigation include: EchoMark/EchoSure (DEVICE), Standard of Care (PROCEDURE).
Who is sponsoring clinical trial NCT06190717?
This trial is sponsored by Sonavex, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06190717 being conducted?
This trial has 20 study locations across Alabama, Arizona, Florida, Illinois, Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Effect of 2-Week Continuous Glucose Monitoring on Glycemic Management in Patients New-to-Insulin on Hospital Discharge
RECRUITING · NA
-
Effects of Whole vs. Nonfat Milk Consumption on Body Composition in Children
RECRUITING · NA
-
Efficacy of Viome's Precision Nutrition Program Towards Reducing HbA1c
RECRUITING · NA
-
Targeting Metabolic Syndrome From the Emergency Department Through Mixed-Methods: Pilot Trial
RECRUITING · NA
-
Bringing Advocacy Via Digital Guide to the Emergency Department (Project BADGE)
RECRUITING · NA
-
Salud Diabetes: A Pilot Study Comparing Lifestyle Interventions and Real-Time Continuous Glucose Monitoring
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.